The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISAL 2023 | Multi-dimensional analysis of the mutational landscape of AML
Monica Cusan, MD, Ludwig-Maximilians University, Munich, Germany, comments on the results of a study that analyzed the mutational profile of patients with acute myeloid leukemia (AML). The study identified three different mutational patterns, and results suggested that the age cutoff used for clinical trial inclusion is not reliable for fit patients above 60 years of age. Dr Cusan further explains how these different mutational patterns affect the outcomes of patients with AML. This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
